Keystone Symposia

Whistler Conference Centre Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

This meeting took place in 2017


Here are the related meetings in 2020:
Tumor Metabolism (C2)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Tumor Metabolism: Mechanisms and Targets (X3)


Organizer(s) Brendan D. Manning, Kathryn E. Wellen and Reuben J. Shaw
March 5—9, 2017
Whistler Conference Centre • Whistler, BC Canada
Discounted Abstract Deadline: Nov 8, 2016
Abstract Deadline: Dec 8, 2016
Scholarship Deadline: Nov 8, 2016
Discounted Registration Deadline: Jan 12, 2017

Sponsored by Bayer HealthCare Pharmaceuticals, Cell Research, Merck & Co., Inc. and Takeda Pharmaceutical Company Limited


Summary of Meeting:
This conference is on the rapidly moving field of tumor metabolism and its implications in cancer development, progression and therapy. Experts from distinct fields of research will be brought together to present their latest discoveries on tumor metabolism, which is an inherently interdisciplinary field. Defining the diversity of metabolic strategies employed by cancer cells and how the genetic events underlying different types of cancer, as well as the tumor microenvironment, influence these metabolic properties is a major goal of this meeting. In addition, a combination of basic, translational and clinical studies will be presented, with the goal of identifying promising avenues in tumor metabolism that impact our understanding, diagnosis and treatment of cancer. In addition to a stellar line up of invited speakers, short talks and poster presentations will provide opportunities for researchers at all levels to discuss their most current work in this field. This meeting provides an excellent opportunity to share knowledge and methodology in tumor metabolism research in a collegial and social atmosphere.

View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 24 hr (international) time


The meeting will begin on Sunday, March 5 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, March 9 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, March 10 in order to fully experience the meeting.

SUNDAY, MARCH 5

4:00—8:00 PM
Arrival and Registration

Grand Foyer
6:00—8:00 PM
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Grand Foyer

MONDAY, MARCH 6

7:00—8:00 AM
Breakfast

Sea to Sky A
8:00—9:00 AM
Welcome and Keynote Address (Joint)

Sea to Sky B/C
* M. Celeste Simon, University of Pennsylvania, USA

Chi Van Dang, University of Pennsylvania, USA
MYC as the Master Regulator of Proliferative Metabolism

9:00—11:30 AM
Hypoxia and Tumor Metabolism (Joint)

Sea to Sky B/C
* Amato J. Giaccia, Stanford University, USA

William G. Kaelin, Jr., Dana-Farber Cancer Institute, USA
2-Oxoglutarate-Dependent Dioxygenases and Cancer

Coffee Break

Nicholas Denko, Ohio State University, USA
Hypoxic Regulation of Mitochondrial Function

Andrew M. Intlekofer, Memorial Sloan Kettering Cancer Center, USA
Short Talk: Acidification Enhances Production of L-2-Hydroxyglutarate through Alternative Substrate use by Dehydrogenase Enzymes

James A. Nathan, Cambridge Institute for Medical Research, UK
Short Talk: Oxygen Sensing and Metabolism: The Role of the 2-Oxoglutarate Dehydrogenase Complex and Mitochondrial Protein Lipoylation

Karen H. Vousden, Francis Crick Institute, UK
A Role for p53 in the Adaptation to Metabolic Stress

11:30 AM—5:00 PM
On Own for Lunch

11:30 AM—1:00 PM
Poster Setup

Sea to Sky A
1:00—10:00 PM
Poster Viewing

Sea to Sky A
2:30—4:30 PM
Workshop 1

Sea to Sky C
* Costas A. Lyssiotis, University of Michigan, USA

Sumin Kang, Emory University, USA
Phosphorylation-Mediated Activation of Lactate Dehydrogenase A Promotes Cancer Cell Invasion and Tumor Metastasis

Issam Ben-Sahra, Northwestern University, USA
Nucleotide Sensing by the mTORC1 Signaling Network

Atsuo T. Sasaki, University of Cincinnati, USA
SSK2 Couples Nucleolar Transcription and Anabolic GTP Metabolism for Gliomagenesis

Isaac Spencer Harris, University of Rochester, USA
Understanding the Vulnerabilities in Cancer Cells Upon Inhibition of Glutathione Synthesis

Won Dong Lee, Princeton University, USA
Inferring Compartmentalized Mitochondrial, Nuclear, and Cytosolic Metabolic Fluxes via Isotope Tracing with Cell Fractionation

Lauren E. Drake, University of Chicago, USA
BNip3 Loss Promotes Hepatocellular Carcinoma Growth through Increased Lipogenesis

Salvador Aznar Benitah, ICREA and Institute for Research in Biomedicine, Spain
Identifying and Targeting Metastatic-Initiating Cells through the Fatty Acid Receptor CD36

Jing Chen, Winship Cancer Institute, Emory University, USA
Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth

4:30—5:00 PM
Coffee Available

Grand Foyer
5:00—7:00 PM
Oncogenic Control of Metabolism

Sea to Sky C
* Heather Christofk, University of California, Los Angeles, USA

Lewis C. Cantley, Weill Cornell Medicine, USA
PI3K Signaling and Glucose Metabolism in Tumors

Almut Schulze, University of Würzburg/Theodor-Boveri Institute, Germany
Targeting Glucose and Lipid Metabolism in Cancer

Brendan D. Manning, Harvard School of Public Health, USA
A Coordinated Anabolic Program Downstream of mTOR

Alejo Efeyan, Spanish National Cancer Research Institute, Spain
Short Talk: Oncogenic Mutations in the Nutrient Sensing Pathway Upstream of mTORC1 Alter B Lymphocyte Functions in Novel Genetically-engineered Mice

5:00—7:00 PM
Hypoxic Influences on Intracellular and Tissue Homeostasis

Sea to Sky B
* Richard K. Bruick, University of Texas Southwestern Medical Center, USA

Young Il Yeom, Korea Research Institute of Bioscience and Biotechnology, South Korea
Lactate-Induced Responses to Hypoxia

Geert Carmeliet, KU Leuven, Belgium
Glutamine, Glycogen and Bioenergetics

Othon Iliopoulos, Massachusetts General Hospital Cancer Center, USA
Glutaminase and PARP Inhibitors Synergistically Suppress ROS and Pyrimidine Dependent Growth of VHL-Deficient Renal Cell Cancer: A Novel Strategy for Treatment of Hypoxia-Driven and HIF-Expressing Tumors

Thomas Markus Leissing, University of Oxford, UK
Short Talk: Structural Basis for the Inhibition of Prolyl-Hydroxylase Domain Containing Proteins (PHDs) by Clinical Candidates for Anaemia Treatment

7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Sea to Sky A
7:30—10:00 PM
Poster Session 1

Sea to Sky A

TUESDAY, MARCH 7

7:00—8:00 AM
Breakfast

Sea to Sky A
8:00—11:15 AM
Metabolic Strategies in Cancer

Sea to Sky C
* Jared Rutter, University of Utah, USA

Matthew G. Vander Heiden, Massachusetts Institute of Technology, USA
Metabolic Adaptations to Allow Tumor Cell Proliferation

Jurre J. Kamphorst, Rheos Medicines, USA
Triglycerides Buffer Membrane Phospholipid Saturation during Hypoxic Stress

Coffee Break

Ralph J. DeBerardinis, University of Texas Southwestern Medical Center, USA
Heterogeneous Metabolic Phenotypes and Liabilities in Human Cancer

Sarah-Maria Fendt, VIB Leuven, Belgium
Cancer Metabolism during Metastasis Formation

Cosimo Commisso, Sanford Burnham Prebys Medical Discovery Institute, USA
Short Talk: Not Dying of Starvation: Nutrient Stress Controls Macropinocytosis in Tumor Cells

Elizabeth Petri Henske, Brigham and Women's Hospital, USA
Short Talk: Therapeutic Targeting of mTORC1-Dependent Metabolic Vulnerabilities in TSC and LAM

8:00—11:15 AM
Physiological Responses to Hypoxia

Sea to Sky B
* Maria F. Czyzyk-Krzeska, University of Cincinnati, USA

Peter F. Carmeliet, University of Leuven, VIB, Belgium
Metabolic Adaptations of Tumor Blood Vessels

Frank S. Lee, University of Pennsylvania School of Medicine, USA
Short Talk: Studies on the Zinc Finger of Prolyl Hydroxylase Domain Protein 2 (PHD2), a Hypoxia Inducible Factor-alpha Hydroxylase

Francisco J. Quintana, Harvard Medical School, USA
Regulation of CNS Inflammation by Hypoxia-Responsive Signaling

Coffee Break

Mark R. Boothby, Vanderbilt University Medical Center, USA
Short Talk: Germinal Center Hypoxia and Regulation of mTORC1 Activity in B Cells Shape Antibody Response Qualities

Janine T. Erler, University of Copenhagen, Denmark
Hypoxia-Driven ECM Remodelling during Cancer Progression

Navdeep S. Chandel, Northwestern University, USA
Why Mammalian Cells Respire?

11:15 AM—5:00 PM
On Own for Lunch

11:15 AM—1:00 PM
Poster Setup

Sea to Sky A
1:00—10:00 PM
Poster Viewing

Sea to Sky A
2:30—4:30 PM
Workshop 1: Fundamental Processes of Oxygen Sensing

Sea to Sky B
James A. Smythies, University of Oxford, UK
Utilisation of Next Generation Sequencing Technologies to Identify Novel Contributors to Hypoxia Inducible Factor Binding Site Selectivity

* Luis del Peso, Universidad Autonoma, Spain
Transcriptional Repression in Hypoxia is Mediated by the Sin3A Histone Deacetylase Complex

Johannes Schödel, Universitätsklinikum Erlangen, Germany
Complex Regulation of Glucose Transporter 3 Expression by HIF

Andrew Fraser, University of Toronto, Canada
How Worms Hold Their Breath: The Unusual Metabolic Response of Nematodes to Hypoxia and the Importance for 2 Billion Humans

Roman Vozdek, University of California, San Francisco, USA
Novel Uncharacterized Protein Tyrosine Kinase Senses Hypoxia to Mediate HIF-1 Independent Transcriptional Response in C. elegans

Austin Gabel, University of Maryland, Baltimore County, USA
Understanding Induction of Suspended Animation In Zebrafish

Farhad B. Imam, Bill & Melinda Gates Foundation, USA
Cellular and Metabolic Studies of Hypoxia-Sensitive Mutants in irs2 and ctrc3, Key Regulators of Glucose and Fatty Acid Metabolism

4:30—5:00 PM
Coffee Available

Grand Foyer
5:00—7:00 PM
Metabolic Adaptations of Cells within the Tumor Microenvironment (Joint)

Sea to Sky B/C
* Erika L. Pearce, Max Planck Institute of Immunobiology and Epigenetics, Germany

Raghu Kalluri, University of Texas MD Anderson Cancer Center, USA
The Functional Contribution of Exosomes in Cancer Metabolism and Metastasis

Randall S. Johnson, University of Cambridge, UK
The Metabolic Role of Hypoxic Response in T Cell Activation

Shannon J. Turley, Genentech, Inc., USA
Leukocyte Function and Positioning in Diverse Stromal Niches

Hong Xie, University of Pennsylvania, USA
Short Talk: Balancing Anabolic Metabolism with Homeostatic Stress Responses in Myc-Transformed Cancer Cells

7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Sea to Sky A
7:30—10:00 PM
Poster Session 2

Sea to Sky A

WEDNESDAY, MARCH 8

7:00—8:00 AM
Breakfast

Sea to Sky A
8:00—11:15 AM
Metabolism, Signaling and Epigenetics

Sea to Sky C
* Matthew G. Vander Heiden, Massachusetts Institute of Technology, USA

Aimee L. Edinger, University of California, Irvine, USA
Macropinocytosis Drives Cancer Cell Growth in Both Nutrient-Limiting and-Replete Conditions

Jason Locasale, Duke University School of Medicine, USA
Diet, Cancer, and Epigenetics

Coffee Break

Joshua D. Rabinowitz, Princeton University, USA
Multiple Functions of Mitochondrial Folate Metabolism

Kathryn E. Wellen, University of Pennsylvania, USA
Acetyl-CoA at the Crossroads of Metabolism and Epigenetics

Christian C. Dibble, Beth Israel Deaconess Medical Center, USA
Short Talk: PI3K Signaling Controls de novo Biosynthesis of Coenzyme A from Vitamin B5

Jordan Meier, NCI, National Institutes of Health, USA
Short Talk: Defining Metabolic Mechanisms of Epigenetic Signaling using Chemoproteomics

8:00—11:15 AM
Biochemical and Epigenetic Responses to Hypoxia

Sea to Sky B
* Frank S. Lee, University of Pennsylvania School of Medicine, USA

Peter J. Ratcliffe, University of Oxford, UK
Genome Wide Studies of the Hypoxia Transcriptome

Daniel Cooper, Duke University School of Medicine, USA
Short Talk: Hypoxia and Radiation Regulate HIF1alpha Gene Targets in a Context-Dependent manner

Fraydoon Rastinejad, University of Oxford, UK
Structures and Drug-Binding Potentials of HIF-alpha-ARNT Heterodimers

Coffee Break

Isha Jain, Massachusetts General Hospital, USA
Short Talk: Hypoxia as a Therapy for Mitochondrial Disease

Eli M. Wallace, Peloton Therapeutics, USA
Small Molecule HIF-2a Antagonists and Their Therapeutic Applications

Maria F. Czyzyk-Krzeska, University of Cincinnati, USA
Oncogenic and Tumor Suppressive Autophagic Programs in Renal Cell Carcinoma

11:15 AM—5:00 PM
On Own for Lunch

11:15 AM—1:00 PM
Poster Setup

Sea to Sky A
1:00—10:00 PM
Poster Viewing

Sea to Sky A
2:30—4:30 PM
Workshop 2

Sea to Sky C
* Aimee L. Edinger, University of California, Irvine, USA

Liron Bar-Peled, The Scripps Research Institute, USA
A Druggable Transcriptional Vulnerability in NRF2-Dependent Lung Cancers

Volkan I. Sayin, Sahlgrenska Cancer Center, Sweden
Somatic Editing of Keap1/Nrf2 Antioxidant Response is Pro-Tumorigenic and Promotes a Targetable Genotype-Dependent Metabolic Switch in KRAS-Driven Lung Cancer

Valeria Santoro, Bayer Pharma AG, Germany
Mitochondrial Folate Transporter (SLC25A32) Protects Against ROS-Mediated Cancer Cell Death

Zhimin Lu, University of Texas MD Anderson Cancer Center, USA
Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy

Boyi Gan, MD Anderson Cancer Center, USA
LncRNA NBR2 Regulates AMPK-Mediated Energy Stress Response and Modulates Cancer Cell Sensitivity to Biguanides

Bin Zheng, Harvard Medical School, USA
Targeting Metabolic Vulnerabilities of MDSCs to Enhance the Anti-Tumor Activity of PD-1 Blockade

Giulia Agnello, Aeglea BioTherapeutics, USA
Therapeutic Depletion of Arginine via Arginase I (AEB1102, Pegzilarginase) Administration Inhibits Tumor Growth and Further Sensitizes the Tumor to Immunotherapy with Anti-PD1 and Anti-PD-L1

Prasenjit Dey, MD Anderson Cancer Center, USA
Collateral Lethality as a Therapeutic Target in Cancer

4:30—5:00 PM
Coffee Available

Grand Foyer
5:00—7:00 PM
Interplay with Other Cell Types and Tissues

Sea to Sky C
* Ralph J. DeBerardinis, University of Texas Southwestern Medical Center, USA

Erika L. Pearce, Max Planck Institute of Immunobiology and Epigenetics, Germany
Biosynthetic Needs of Immune Cells and Effects on Immunotherapy

Nada Y. Kalaany, Boston Children's Hospital at Harvard Medical School, USA
Metabolic Dependencies in Obesity-Associated Pancreatic Cancer

Scott Bultman, University of North Carolina at Chapel Hill, USA
Regulation of Tumor Metabolism by the Microbiome

Costas A. Lyssiotis, University of Michigan, USA
Short Talk: Stromal Support of Pancreatic Tumor Metabolism

5:00—7:00 PM
Hypoxia and the Tumor Stroma

Sea to Sky B
* Ester M. Hammond, University of Oxford, UK

M. Celeste Simon, University of Pennsylvania, USA
HIFs and Metabolic Adaptations in Renal Cancer

Mia J. Phillipson, Uppsala University, Sweden
Contribution of Immune Cells in Restoration of Hypoxic Tissues

Sonia Rocha, University of Liverpool, UK
PBRM1, a Highly Mutated Member of the SWI/SNF Complex in Renal Cancer, has an Unconventional Role in the Control of the Hypoxia Response

Jong Park, University of Maryland, Baltimore County, USA
Short Talk: Role of Lactate-NDRG Signaling in Low Oxygen Tolerance

7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Sea to Sky A
7:30—10:00 PM
Poster Session 3

Sea to Sky A

THURSDAY, MARCH 9

7:00—8:00 AM
Breakfast

Sea to Sky A
7:30—8:00 AM
Poster Setup

Sea to Sky A
8:00 AM—12:00 PM
Poster Viewing

Sea to Sky A
8:00—11:15 AM
Tumor Progression and Suppression by Metabolic Enzymes

Sea to Sky C
* Sarah-Maria Fendt, VIB Leuven, Belgium

David M. Sabatini, Whitehead Institute for Biomedical Research, USA
CRISPR Screening for Metabolic Dependencies in Cancer Cells

Jared Rutter, University of Utah, USA
Pyruvate Metabolism and Cell Fate Decisions

Coffee Break

Heather Christofk, University of California, Los Angeles, USA
Metabolic Transitions in Cancer: Lessons from Viral Infection

Eyal Gottlieb, Technion - Israel Institute of Technology, Israel
Metabolic Dependencies of Leukemic Stem Cells

Oliver Maddocks, University of Glasgow, UK
Short Talk: MTAP Deletion and Polyamine Pathway Activity Combine to Confer Cysteine Essentiality in Cancer Cells

Susan Demo, Calithera Biosciences, USA
Short Talk: CB-839, a Selective Glutaminase Inhibitor, has Anti-Tumor Activity in Renal Cell Carcinoma and Synergizes with Everolimus and Cabozantinib

8:00—11:15 AM
Hypoxia, Inflammation and Tumor Progression

Sea to Sky B
* Emin Maltepe, University of California, San Francisco, USA

Amato J. Giaccia, Stanford University, USA
Clear Cell Renal Cancers: Lipid Droplets

Cormac Taylor, University College Dublin, Ireland
The Role of Hypoxia in Immunity and Inflammation

G-One Ahn, Pohang University of Science and Technology, South Korea
Short Talk: Tumor-Associated Macrophages Can Exacerbate Tumor Hypoxia and Glycolysis

Coffee Break

Gregg L. Semenza, Johns Hopkins University School of Medicine, USA
PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance and Lung Metastasis

Christian Metallo, University of California, San Diego, USA
Reprogramming of Amino Acid Metabolism by Hypoxia

Erinn B. Rankin, Stanford University, USA
Short Talk: Hypoxic Signaling in the Tumor-Mesothelial Niche

11:15 AM—12:15 PM
Lunch

Sea to Sky A
12:00—2:30 PM
Poster Session 4

Sea to Sky A
2:30—4:30 PM
Workshop 2: Hypoxia and Disease Processes

Sea to Sky B
* Peppi Koivunen, University of Oulu, Finland
Notch Downregulation and Extramedullary Erythrocytosis in HIF Prolyl 4-Hydroxylase-2-Deficient Mice

* Qing Zhang, University of North Carolina at Chapel Hill, USA
ZHX2 Promotes ccRCC as a Potential pVHL Target by Activating NF-kB

Jason Boehme, University of California, San Francisco, USA
Preservation of Myocardial Contractility during Acute Hypoxia with OMX—A Novel Oxygen Delivery Biotherapeutic

Sara M. Timpano, University of Guelph, Canada
Human Cells Cultured Under Physiological Oxygen Utilize a Different Mode of Translation Initiation, Have Higher Proliferation Rates, Less Oxidized DNA and More Tubular Mitochondria

Norihiko Takeda, University of Tokyo, Japan
HIF-1-PDK1 Axis Induced Active Glycolysis Plays an Essential Role in Macrophage Migratory Capacity

Merve Erdem, Uniklinik Aachen, Germany
HIF-1alpha in Myeloid Cells Affects Peripheral Lipid Metabolism in Cancer Cachexia

Jamie D. Weyandt, Vanderbilt University Medical Center, USA
Loss of Fumarate Hydratase Upregulates Glycolytic Metabolism in a Mouse Renal Carcinoma Cell Line

4:30—5:00 PM
Coffee Available

Grand Foyer
5:00—6:45 PM
Metabolic Vulnerabilities in Cancer

Sea to Sky C
* Almut Schulze, University of Würzburg/Theodor-Boveri Institute, Germany

Eileen P. White, Rutgers University, USA
Inhibiting Autophagy as a Cancer Therapy

Katya Marjon, Agios Pharmaceuticals, USA
Metabolic Collateral Vulnerabilities of MTAP-Deleted Cancers as Therapeutic Opportunities

Reuben J. Shaw, The Salk Institute for Biological Studies, USA
The AMPK Pathway: Cancer Fighter, Cancer Promoter

5:00—6:45 PM
O2 Availability and Stress Responses

Sea to Sky B
* Randall S. Johnson, University of Cambridge, UK

Constantinos Koumenis, University of Pennsylvania, USA
Genome-Wide Analysis of Hypoxic Responses in Cells and Tumors Reveals Novel Splicing Pathways Impacting Macromolecular Synthesis

Bradly G. Wouters, University Health Network, Canada
ULK1 Regulates Oxygen Metabolism, Hypoxia Tolerance and Is a Therapeutic Target in Pancreatic Cancer

Ester M. Hammond, University of Oxford, UK
Ribonucleotide Reductase Favors the RRM2B Subunit to Maintain DNA Replication in Hypoxia

6:45—7:00 PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)

Sea to Sky C
6:45—7:00 PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)

Sea to Sky B
7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Sea to Sky A
8:00—11:00 PM
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Sea to Sky A

FRIDAY, MARCH 10

 
Departure


*Session Chair †Invited, not yet responded.


We gratefully acknowledge support for this conference from:


Directors' Fund

These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.

Keystone Symposia thanks our Sponsors(s) for generously supporting this meeting:

Bayer HealthCare Pharmaceuticals Cell Research
Merck & Co., Inc. Takeda Pharmaceutical Company Limited

We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1R13CA213447-01

Funding for this conference was made possible (in part) by 1R13CA213447-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

We gratefully acknowledge additional support for this conference from:

Bethyl Laboratories, Inc. Xcell Biosciences

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

BioMed Central Ltd - Cancer and Metabolism Journal

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations

If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Corporate Relations, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Nick Dua, Senior Director, Communications, Email: nickd@keystonesymposia.org,
Phone:+1 970-262-1179